{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:01:58Z","timestamp":1761843718859},"reference-count":30,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1157\/13111418","type":"journal-article","created":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T17:14:54Z","timestamp":1194628494000},"page":"521-524","source":"Crossref","is-referenced-by-count":9,"title":["Variabilidad en la valoraci\u00f3n del riesgo coronario en pacientes infectados por el virus de la inmunodeficiencia humana"],"prefix":"10.1016","volume":"129","author":[{"given":"Milagros","family":"Garc\u00eda-L\u00e1zaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngela","family":"Camacho Espejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"P\u00e9rez-Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Natera Kindel\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Cast\u00f3n Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"de la Torre Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13111418_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0025-7753(00)71473-4","article-title":"Evoluci\u00f3n del n\u00famero de personas infectadas por el virus de la inmunodeficiencia humana y de los casos de sida en Espa\u00f1a","volume":"115","author":"Castilla","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1157\/13058676","article-title":"Riesgo vascular e infecci\u00f3n por el virus de la inmunodeficiencia humana tipo 1","volume":"122","author":"Dronda","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/00002030-200305230-00010","article-title":"Cardiovascular disease risk factors in HIV patients association with antiretroviral therapy: results from the DAD study","volume":"17","author":"Friis-Moller","year":"2003","journal-title":"AIDS"},{"key":"10.1157\/13111418_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1157\/13062189","article-title":"Distribuci\u00f3n anormal de la grasa corporal y tipo de tratamiento antirretroviral como predictores de riesgo de enfermedad cardiovascular en pacientes infectados por el virus de la inmunodeficiencia humana","volume":"122","author":"Ena","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1157\/13074397","article-title":"Riesgo cardiovascular e infecci\u00f3n por el virus de la inmunodeficiencia humana en pacientes internados en centros penitenciarios [carta]","volume":"124","author":"Mauri","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1097\/00126334-200209011-00004","article-title":"Cardiovascular risk associated UIT HIV therapy","volume":"31","author":"Currier","year":"2002","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1157\/13111418_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"An updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1157\/13111418_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ije\/31.4.817","article-title":"A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study","volume":"31","author":"Thomsen","year":"2002","journal-title":"Int J Epidemiol"},{"key":"10.1157\/13111418_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/01.CIR.104.4.491","article-title":"Cardiovascular risk assessment based on US cohort studies: findings from a National Heart, Lung, and Blood Institute Workshop","volume":"104","author":"Grundy","year":"2001","journal-title":"Circulation"},{"key":"10.1157\/13111418_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/euhj.1999.1864","article-title":"Comparison of the Framingham risk-function-based coronary chart with risk function from an Italian population study","volume":"21","author":"Menotti","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1157\/13111418_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/heart.84.3.238","article-title":"Coronary heart disease incidence in northern and southern European population: a reanalysis of the seven countries studiy for a European coronary risk chart","volume":"84","author":"Menotti","year":"2000","journal-title":"Heart"},{"key":"10.1157\/13111418_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/S0195-668X(03)00347-6","article-title":"European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice","volume":"24","author":"De Backer","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1157\/13111418_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1157\/13043951","article-title":"Estimaci\u00f3n del riesgo coronario en Espa\u00f1a mediante la ecuaci\u00f3n de Framingham calibrada","volume":"56","author":"Marrugat","year":"2003","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13111418_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0300-8932(01)76472-X","article-title":"Factores de riesgo y morbimortalidad coronaria en una cohorte laboral mediterr\u00e1nea seguida durante 28 a\u00f1os. Estudio Manresa","volume":"54","author":"Tomas","year":"2001","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13111418_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jech.52.11.707","article-title":"High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence","volume":"52","author":"Masi\u00e1","year":"1988","journal-title":"J Epidemiol Community Heart"},{"key":"10.1157\/13111418_bib16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ije\/27.4.599","article-title":"Acute myocardial infarction case fatality, incidence and mortality rates in a population registry in Girona, Spain, 1990-1992","volume":"27","author":"P\u00e9rez","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1157\/13111418_bib17","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1023\/B:EJEP.0000040531.77638.17","article-title":"Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998","volume":"19","author":"Marrugat","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1157\/13111418_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1157\/13053388","article-title":"Comparaci\u00f3n de la funci\u00f3n de Framingham original y la calibrada del REGICOR en la predicci\u00f3n del riesgo coronario poblacional","volume":"121","author":"Ramos","year":"2003","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1157\/13078127","article-title":"Ecuaci\u00f3n de Framingham de Wilson y ecuaci\u00f3n de REGICOR. Estudio comparativo","volume":"58","author":"Crist\u00f3bal","year":"2005","journal-title":"Rev Esp Cardiol"},{"key":"10.1157\/13111418_bib20","unstructured":"Mart\u00ednez E, Arribas JR, L\u00f3pez-Aldeguer J, Guti\u00e9rrez F, Miralles C, Lozano F, et al. Factors associated with a high cardiovascular risk in HIV-infected patients in Spain: a multicenter, nation-wide, cross-sectional study [resumen 49LB, p\u00f3ster 870]. Actas de 12th Conference on Retroviruses and Opportunistic Infections; 2005, febrero 22-25; Boston. Boston: CROI; 2005."},{"key":"10.1157\/13111418_bib21","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(02)11672-2","article-title":"Protease inhibitors and cardiovascular outcomes in patients with HIV-1","volume":"360","author":"Holmberg","year":"2002","journal-title":"Lancet"},{"key":"10.1157\/13111418_bib22","doi-asserted-by":"crossref","unstructured":"The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral treatment and risk of myocardial infarction. N Engl J Med. 2003;349:1993-2003 (fede errores en: N Engl J Med. 2004;350:955).","DOI":"10.1056\/NEJM200402263500927"},{"key":"10.1157\/13111418_bib23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1157\/13058678","article-title":"Enfermedad cardiovascular sintom\u00e1tica en pacientes infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral de gran actividad","volume":"122","author":"Jerico","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13111418_bib24","unstructured":"Mart\u00ednez E, Fern\u00e1ndez-Miranda C, Conget I, Moreno S, Santamar\u00eda JM, Boix V, et al. Actitud ante las alteraciones metab\u00f3licas y de distribuci\u00f3n de la grasa corporal en pacientes infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral. Documento de Consenso de GESIDA y del Plan Nacional sobre el SIDA. En: Grupo de Estudio de Sida (GESIDA) de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC), editores. Terapia antirretroviral y enfermedades asociadas el VIH (2000-2002). Madrid: Doyma SL; 2002. p. 157-71."},{"key":"10.1157\/13111418_bib25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/317429","article-title":"Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trials Group Cardiovascular Disease Focus Group","volume":"31","author":"Dube","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13111418_bib26","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-445.","DOI":"10.1161\/01.CIR.89.3.1333"},{"key":"10.1157\/13111418_bib27","doi-asserted-by":"crossref","unstructured":"Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285: 2486-97.","DOI":"10.1001\/jama.285.19.2486"},{"issue":"Suppl A","key":"10.1157\/13111418_bib28","first-page":"2","article-title":"The M\u00fcnster Heart Study (PROCAM). Results of follow-up at 8 years","volume":"19","author":"Assmann","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1157\/13111418_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of tenyear risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1157\/13111418_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jech.2005.038505","article-title":"Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study","volume":"61","author":"Marrugat","year":"2007","journal-title":"J Epidemiol Community Health"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307729056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T08:52:22Z","timestamp":1556959942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307729056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":30,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0025775307729056"],"URL":"https:\/\/doi.org\/10.1157\/13111418","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}